UPS Stock Has 22% Upside, According to 1 Wall Street Analyst
Published
The company's investor day presentation didn't quite go as planned.
Full ArticlePublished
The company's investor day presentation didn't quite go as planned.
Full ArticleBiotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.
Will these catalysts be enough to support the stock's high valuation?